Literature DB >> 22272753

Lillie shockney: breast cancer survivor, advocate, and researcher.

John F P Bridges1.   

Abstract

Entities:  

Year:  2008        PMID： 22272753     DOI： 10.2165/01312067-200801010-00003

Source DB:  PubMed          Journal:  Patient        ISSN： 1178-1653            Impact factor:   3.883


× No keyword cloud information.
  4 in total

1.  Honoring pioneers in patient-centered outcomes research.

Authors:  John F P Bridges; Christopher I Carswell
Journal:  Patient       Date:  2008-01-01       Impact factor: 3.883

2.  Can pharmacoeconomics and outcomes research contribute to the empowerment of women affected by breast cancer?

Authors:  Jessica T Lee; John Fp Bridges; Lillie Shockney
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2008-02       Impact factor: 2.217

3.  Cost-benefit analysis of a follow-up program in patients with breast cancer: a randomized prospective study.

Authors:  Amparo Oltra; A Santaballa; B Munárriz; M Pastor; J Montalar
Journal:  Breast J       Date:  2007 Nov-Dec       Impact factor: 2.431

4.  Symptom-oriented follow-up of early breast cancer is not inferior to conventional control. Results of a prospective multicentre study.

Authors:  Sven Bornhak; Else Heidemann; Hans-Joachim Herschlein; Wolfgang Simon; Elisabeth Merkle; Günter Widmaier; Rainer Ernst; Michael Greulich; Reinhard Bittner; Günther Kieninger; Peter Merkle; Helmut Strosche; Cornelius Karg; Ulrich Wellhaeusser; Walter Aulitzky; Bernhardt Schmidt; Helmut Metzger; Meike Hahn; Anette Stauch; Christoph Meisner; Hans-Konrad Selbmann; Christine Regelmann; Friedhelm Brinkmann
Journal:  Onkologie       Date:  2007-09-07
  4 in total
  2 in total

1.  The role of the patient in promoting patient-centered outcomes research.

Authors:  Michael J Klag; Ellen J Mackenzie; Christopher I Carswell; John F P Bridges
Journal:  Patient       Date:  2008-01-01       Impact factor: 3.883

2.  Honoring pioneers in patient-centered outcomes research.

Authors:  John F P Bridges; Christopher I Carswell
Journal:  Patient       Date:  2008-01-01       Impact factor: 3.883
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.